06/18/2026
A telemedicine-based diabetes clinic serving incarcerated men in Illinois produced clinically significant reductions in hemoglobin A1c (HbA1c) and improvements in several standard-of-care measures over 18 months, according to a quality improvement study published in JAMA Network Open.
An 18-month Illinois pilot linking prison clinicians to endocrinologists via telehealth achieved a mean HbA1c reduction of 1.6 percentage points across 115 incarcerated men with diabetes.